Evidence map›Paper›PMID 30446581›Full record

ArticleThe oncologist2019

Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.

George Simon, Courtney D DiNardo, Koichi Takahashi, Tina Cascone, Cynthia Powers, Rick Stevens, Joshua Allen, Mara B Antonoff, Daniel Gomez, Pat Keane and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Artificial intelligence: A new tool in surgeon's hand.Journal of education and health promotion · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 2 institutions in 1 country.

George SimonDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Courtney D DiNardoDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Koichi TakahashiDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Tina CasconeDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Cynthia PowersDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Rick StevensIBM Watson Health, Cambridge, Massachusetts, USA.
Joshua AllenIBM Watson, New York New York, USA.
Mara B AntonoffDepartment of Thoracic & Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA.
Daniel GomezDepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Pat KeaneIBM Watson Health, Cambridge, Massachusetts, USA.
Fernando Suarez SaizIBM Watson Health, Cambridge, Massachusetts, USA.
Quynh NguyenDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Emily RoartyDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Sherry PierceDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Jianjun ZhangDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Emily Hardeman BarnhillDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Kate LakhaniDepartment of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Kenna ShawDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
Brett SmithDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
Stephen SwisherDepartment of Thoracic & Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA.
Rob HighIBM Watson, New York New York, USA.
P Andrew FutrealDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
John HeymachDepartment of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Lynda ChinDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA lchin@utsystem.edu.
The University of Texas MD Anderson Cancer Center · USIBM (United States) · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

backgroundRapid advances in science challenge the timely adoption of evidence-based care in community settings. To bridge the gap between what is possible and what is practiced, we researched approaches to developing an artificial intelligence (AI) application that can provide real-time patient-specific decision support. MATERIALS AND

methodsThe Oncology Expert Advisor (OEA) was designed to simulate peer-to-peer consultation with three core functions: patient history summarization, treatment options recommendation, and management advisory. Machine-learning algorithms were trained to construct a dynamic summary of patients cancer history and to suggest approved therapy or investigative trial options. All patient data used were retrospectively accrued. Ground truth was established for approximately 1,000 unique patients. The full Medline database of more than 23 million published abstracts was used as the literature corpus.

resultsOEA's accuracies of searching disparate sources within electronic medical records to extract complex clinical concepts from unstructured text documents varied, with F1 scores of 90%-96% for non-time-dependent concepts (e.g., diagnosis) and F1 scores of 63%-65% for time-dependent concepts (e.g., therapy history timeline). Based on constructed patient profiles, OEA suggests approved therapy options linked to supporting evidence (99.9% recall; 88% precision), and screens for eligible clinical trials on ClinicalTrials.gov (97.9% recall; 96.9% precision).

conclusionOur results demonstrated technical feasibility of an AI-powered application to construct longitudinal patient profiles in context and to suggest evidence-based treatment and trial options. Our experience highlighted the necessity of collaboration across clinical and AI domains, and the requirement of clinical expertise throughout the process, from design to training to testing. IMPLICATIONS FOR PRACTICE: Artificial intelligence (AI)-powered digital advisors such as the Oncology Expert Advisor have the potential to augment the capacity and update the knowledge base of practicing oncologists. By constructing dynamic patient profiles from disparate data sources and organizing and vetting vast literature for relevance to a specific patient, such AI applications could empower oncologists to consider all therapy options based on the latest scientific evidence for their patients, and help them spend less time on information "hunting and gathering" and more time with the patients. However, realization of this will require not only AI technology maturation but also active participation and leadership by clincial experts.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalClinical Decision-MakingClinical Trials as TopicElectronic Health RecordsEvidence-Based MedicineFeasibility StudiesHumansMedical OncologyNeoplasmsPatient SelectionArtificial intelligence application in medicineClinical decision supportClosing the cancer care gapDemocratization of evidence‐based careVirtual expert advisor

Identifiers

PMID30446581
PMCPMC6656515
OpenAlexW2900565551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.